EGF Theramed Health (AUH) AI Stock Analysis

Top Page

EGF Theramed Health

(Frankfurt:AUH)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Improving Cash GenerationThe shift to slightly positive operating and free cash flow in 2025 signals emerging cash generation after several years of negative flows. Although the amount is small, sustained positive cash flow would reduce near-term financing needs and provide a foundation for incremental investment or product commercialization.

Negative Factors

No Reported RevenueZero reported revenue across the available periods shows the company lacks commercialized products or monetization. Without recurring revenue, long-term viability depends on successful product launches or continual external funding, substantially increasing execution and dilution risk for stakeholders.

EGF Theramed Health (AUH) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 813.17K
Dividend Yield: ―
Average Volume (3M): 2,005
Price to Earnings (P/E): -0.4
Beta (1Y): -1.58
Revenue Growth: ―
EPS Growth: 70.01%
Country: Germany
Employees: 0
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Healthcare Information Services

EGF Theramed Health Business Overview & Revenue Model

Company Description

EGF Theramed Health Corp. focuses on providing psychedelic-based therapies to address various mental health challenges. The company's products are specifically utilized in the treatment of conditions such as intractable depression, anxiety disorders,...

EGF Theramed Health Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:AUH against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:NDAT	45Neutral	CAD 2.89M	-16.67	-49.83%	―	―	0.00%
TSE:DMED	39Underperform	CAD 3.95M	-1.94	739.84%	―	―	-28.35%
TSE:KETA	38Underperform	CAD 3.31M	-19.19	8.34%	―	―	―
TSE:NARA	38Underperform	CAD 2.39M	-0.82	184.91%	―	―	43.30%

* Healthcare Sector Average

Performance Comparison

DE:AUH and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:AUH	Egf Theramed Health Corp.	0.03	-0.02	-33.33%
TSE:NDAT	nDatalyze Corp	0.07	0.06	366.67%
TSE:KETA	TripSitter Clinic Ltd	0.19	0.09	90.00%
TSE:NARA	PanGenomic Health, Inc. Class A	0.17	-1.03	-85.83%
TSE:DMED	DiagnaMed Holdings Corp.	0.03	-0.06	-66.67%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

EGF Theramed Health AI Stock Analysis

Top Page